These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors. Almebayadh M; Regnier-Rosencher E; Carlotti A; Goulvestre C; Le Guern V; Mouthon L; Avril MF; Dupin N Dermatology; 2013; 226(2):119-23. PubMed ID: 23548825 [TBL] [Abstract][Full Text] [Related]
28. Pantoprazole-Associated Thrombocytopenia: A Literature Review and Case Report. Phan AT; Tseng AW; Choudhery MW; Makar JB; Nguyen C; Farmand F Cureus; 2022 Feb; 14(2):e22326. PubMed ID: 35371663 [TBL] [Abstract][Full Text] [Related]
29. Lessons from two cases of anaphylaxis to proton pump inhibitors. Choi SW; Han JM; Bae YJ; Lee YS; Cho YS; Moon HB; Kim TB J Clin Pharm Ther; 2012 Oct; 37(5):614-6. PubMed ID: 22642701 [TBL] [Abstract][Full Text] [Related]
30. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us? Luk CP; Parsons R; Lee YP; Hughes JD Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281 [TBL] [Abstract][Full Text] [Related]
31. A Case of Pantoprazole Anaphylaxis with Cross Reactivity to All Proton Pump Inhibitors: Finding a Safe Alternative. Turedi O; Sozener ZC; Kendirlinan R; Bavbek S Curr Drug Saf; 2017; 12(3):198-200. PubMed ID: 28699491 [TBL] [Abstract][Full Text] [Related]
32. Impact of oesophagitis classification in evaluating healing of erosive oesophagitis after therapy with proton pump inhibitors: a pooled analysis. Yaghoobi M; Padol S; Yuan Y; Hunt RH Eur J Gastroenterol Hepatol; 2010 May; 22(5):583-90. PubMed ID: 20061959 [TBL] [Abstract][Full Text] [Related]
33. Analysis of cytopenia in geriatric inpatients. Röhrig G; Becker I; Pappas K; Polidori MC; Schulz RJ Z Gerontol Geriatr; 2018 Feb; 51(2):231-236. PubMed ID: 28660533 [TBL] [Abstract][Full Text] [Related]
34. Nine cases of omeprazole allergy: cross-reactivity between proton pump inhibitors. Lobera T; Navarro B; Del Pozo MD; González I; Blasco A; Escudero R; Venturini M; Alarcón E J Investig Allergol Clin Immunol; 2009; 19(1):57-60. PubMed ID: 19274931 [TBL] [Abstract][Full Text] [Related]
35. The prevalence of pantoprozole associated thrombocytopenia in a community hospital. Dotan E; Katz R; Bratcher J; Wasserman C; Liebman M; Panagopoulos G; Spaccavento C Expert Opin Pharmacother; 2007 Sep; 8(13):2025-8. PubMed ID: 17714057 [TBL] [Abstract][Full Text] [Related]
36. Evaluation and management of hypersensitivity to proton pump inhibitors. Bose S; Guyer A; Long A; Banerji A Ann Allergy Asthma Immunol; 2013 Dec; 111(6):452-7. PubMed ID: 24267357 [TBL] [Abstract][Full Text] [Related]
37. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians. Tran M; Tafreshi J; Pai RG J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037 [TBL] [Abstract][Full Text] [Related]
38. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome. Hsiao FY; Mullins CD; Wen YW; Huang WF; Chen PF; Tsai YW Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole. Andersson T Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397 [TBL] [Abstract][Full Text] [Related]
40. The relationship among proton pump inhibitors, bone disease and fracture. Targownik LE; Leslie WD Expert Opin Drug Saf; 2011 Nov; 10(6):901-12. PubMed ID: 21599546 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]